Cargando…
Dynamic and Multi-Pharmacophore Modeling for Designing Polo-Box Domain Inhibitors
The polo-like kinase 1 (Plk1) is a critical regulator of cell division that is overexpressed in many types of tumors. Thus, a strategy in the treatment of cancer has been to target the kinase activity (ATPase domain) or substrate-binding domain (Polo-box Domain, PBD) of Plk1. However, only few synth...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4103762/ https://www.ncbi.nlm.nih.gov/pubmed/25036740 http://dx.doi.org/10.1371/journal.pone.0101405 |